Younis, T., Rayson, D., & Skedgel, C. (2011). The cost–utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer. Multimed Inc.
Citación estilo ChicagoYounis, T., D. Rayson, and C. Skedgel. The Cost–utility of Adjuvant Chemotherapy Using Docetaxel and Cyclophosphamide Compared With Doxorubicin and Cyclophosphamide in Breast Cancer. Multimed Inc, 2011.
Cita MLAYounis, T., D. Rayson, and C. Skedgel. The Cost–utility of Adjuvant Chemotherapy Using Docetaxel and Cyclophosphamide Compared With Doxorubicin and Cyclophosphamide in Breast Cancer. Multimed Inc, 2011.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.